{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:36:24Z","timestamp":1791128184444,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/aog.0b013e3181e45951","type":"journal-article","created":{"date-parts":[[2010,6,17]],"date-time":"2010-06-17T07:06:49Z","timestamp":1276758409000},"page":"147-159","source":"Crossref","is-referenced-by-count":133,"title":["Lamivudine in Late Pregnancy to Interrupt In Utero Transmission of Hepatitis B Virus"],"prefix":"10.1097","volume":"116","author":[{"given":"Zhongjie","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuebo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20210126","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00002512-200118100-00002","article-title":"Current management strategies for hepatitis B in the elderly.","volume":"18","author":"Merle","year":"2001","journal-title":"Drugs Aging"},{"key":"R2-25-20210126","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0929-693X(00)80199-2","article-title":"Mother-child transmission of hepatitis B virus. State of the problem and prevention.","volume":"7","author":"Hamdani-Belghiti","year":"2000","journal-title":"Arch Pediatr"},{"key":"R5-25-20210126","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States.","volume":"55","author":"Mast","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R6-25-20210126","first-page":"473","article-title":"Persistent HBsAg antigenemia in newborn infants following intrauterine HBV infection. Cause for the failure of the prevention of perinatal HBV transmission.","volume":"134","author":"Pongpipat","year":"1986","journal-title":"Monatsschr Kinderheilkd"},{"key":"R7-25-20210126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2334-10-26","article-title":"Survey of HBsAg-positive pregnant women and their infants regarding measures to prevent maternal-infantile transmission.","volume":"10","author":"Guo","year":"2010","journal-title":"BMC Infectious Diseases"},{"key":"R8-25-20210126","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.3748\/wjg.v10.i21.3215","article-title":"Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection.","volume":"10","author":"Li","year":"2004","journal-title":"World J Gastroenterol"},{"key":"R9-25-20210126","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1365-2893.2003.00440.x","article-title":"Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection.","volume":"10","author":"van Zonneveld","year":"2003","journal-title":"J Viral Hepat"},{"key":"R10-25-20210126","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0140-6736(02)08425-8","article-title":"Vertical transmission of hepatitis B virus despite maternal lamivudine therapy.","volume":"359","author":"Kazim","year":"2002","journal-title":"Lancet"},{"key":"R11-25-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"R14-25-20210126","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/bmj.322.7300.1479","article-title":"Forest plots: trying to see the wood and the trees.","volume":"322","author":"Lewis","year":"2001","journal-title":"BMJ"},{"key":"R15-25-20210126","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychol Methods"},{"key":"R16-25-20210126","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/016327870102400203","article-title":"Methods for exploring heterogeneity in meta-analysis.","volume":"24","author":"Song","year":"2001","journal-title":"Eval Health Prof"},{"key":"R17-25-20210126","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis.","volume":"54","author":"Sterne","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"R18-25-20210126","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3748\/wjg.v9.i7.1501","article-title":"Interruption of HBV intrauterine transmission: a clinical study.","volume":"9","author":"Li","year":"2003","journal-title":"World J Gastroenterol"},{"key":"R19-25-20210126","first-page":"77","article-title":"Study of Lamivudine in interruption of HBV intrauterine infection.","volume":"21","author":"Shi","year":"2005","journal-title":"Clin Med Chin"},{"key":"R20-25-20210126","first-page":"378","article-title":"Effect and safety of preventing HBV vertical transmission by lamivudine treatment.","volume":"44","author":"Han","year":"2005","journal-title":"Chin J Intern Med"},{"key":"R21-25-20210126","first-page":"106","article-title":"Clinical effect and safety of lamivudine in interruption of chronic HBV maternal to infant transmission.","volume":"11","author":"Li","year":"2006","journal-title":"Chin Hepatol"},{"key":"R22-25-20210126","first-page":"1019","article-title":"Effect on interruption of hepatitis B virus vertical transmission by lamivudine.","volume":"22","author":"Feng","year":"2007","journal-title":"J Appl Clin Pediatr"},{"key":"R23-25-20210126","first-page":"14","article-title":"Evaluation of therapeutic effect in HBV vertical transmission by lamivudine treatment combined with active-passive immunization for pregnant women.","volume":"2","author":"Xiang","year":"2007","journal-title":"Chin Prac Med"},{"key":"R24-25-20210126","first-page":"76","article-title":"The clinical observation of effect of lamivudine on blocking mother to infant transmission of chronic HBV.","volume":"14","author":"Yang","year":"2008","journal-title":"Int Med Health Guid News"},{"key":"R25-25-20210126","first-page":"329","article-title":"Effect of high viral hepatitis B virus DNA loads on vertical transmission of hepatitis B virus in late-pregnant women.","volume":"43","author":"Yang","year":"2008","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"R26-25-20210126","article-title":"Clinical research on the interruption of mother to child transmission of HBV- a randomized, double-blind, placebo-control study. Unite for Site 6th Annual Global Health Conference.","author":"Shi","year":"2009"},{"key":"R27-25-20210126","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2893.2008.01056.x","article-title":"Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.","volume":"16","author":"Xu","year":"2009","journal-title":"J Viral Hepat"},{"key":"R28-25-20210126","first-page":"547","article-title":"Clinical study on the prevention of HBV from mother to infant by injection of hepatitis B immunoglobulin in pregnant women with HBsAg.","volume":"15","author":"Yue","year":"1999","journal-title":"Chin J Prac Gynecol Obstet"},{"key":"R29-25-20210126","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003088-199936010-00004","article-title":"Clinical pharmacokinetics of lamivudine.","volume":"36","author":"Johnson","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"R30-25-20210126","first-page":"392","article-title":"The role of placenta in hepatitis B virus intrauterine transmission.","volume":"34","author":"Yan","year":"1999","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"R31-25-20210126","first-page":"654","article-title":"Study on hepatitis B virus infection status in placentas of hepatitis B surface antigen positive pregnant women during middle and late period of pregnancy.","volume":"35","author":"Ma","year":"2000","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"R33-25-20210126","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM199512213332501","article-title":"A preliminary trial of lamivudine for chronic hepatitis B infection.","volume":"333","author":"Dienstag","year":"1995","journal-title":"N Engl J Med"},{"key":"R34-25-20210126","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/hep.510250144","article-title":"Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.","volume":"25","author":"Lai","year":"1997","journal-title":"Hepatology"},{"key":"R35-25-20210126","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.281.2.151","article-title":"Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV infected women. Pediatric AIDS Clinical Trials Group Protocol 219\/076 Teams.","volume":"281","author":"Culnane","year":"1999","journal-title":"JAMA"},{"key":"R36-25-20210126","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of Maternal-Infant transmission of Human Immunodeficiency virus type-1 with Zidovudine. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"R37-25-20210126","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1872-034X.2007.00292.x","article-title":"Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine.","volume":"38","author":"Kurashige","year":"2008","journal-title":"Hepatol Res"},{"key":"R38-25-20210126","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ajog.2004.05.061","article-title":"Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy.","volume":"191","author":"Watts","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R39-25-20210126","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(83)90624-4","article-title":"Prevention of perinatally transmission hepatitis B virus infection with hepatitis B immune globulin and hepatitis B vaccine.","volume":"2","author":"Beasley","year":"1983","journal-title":"Lancet"},{"key":"R40-25-20210126","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.3748\/wjg.v11.i23.3582","article-title":"Transformation of hepatitis B serologic markers in babies born to hepatitis B surface antigen positive mothers.","volume":"11","author":"Wang","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R41-25-20210126","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3748\/wjg.v4.i1.61","article-title":"Relationship between HBV viremia level of pregnant women and intrauterine infection:neated PCR for detection of HBV DNA.","volume":"4","author":"Zhang","year":"1998","journal-title":"World J Gastroenterol"},{"key":"R42-25-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0166-0934(87)90070-X","article-title":"Perinatal transmission of hepatitis B virus in high-incidence countries.","volume":"17","author":"Ghendon","year":"1987","journal-title":"J Virol Methods"},{"key":"R43-25-20210126","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0264-410X(99)00320-5","article-title":"Long-term efficacy of immunization against hepatitis B virus in infants at high-risk analyzed by polymerase chain reaction.","volume":"18","author":"Kato","year":"2000","journal-title":"Vaccine"},{"key":"R44-25-20210126","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/514610","article-title":"Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors.","volume":"27","author":"Ngui","year":"1998","journal-title":"Clin Infect Dis"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-201007000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:25:11Z","timestamp":1786040711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201007000-00025"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3181e45951","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.4627956.4505054","asserted-by":"object"}]},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}